[1]
2025. BREAKTHROUGH CAR-T THERAPY IN REFRACTORY B-CELL LYMPHOMA: MIOT INTERNATIONAL CHENNAI, INDIA CASE STUDY. Herald of the National Children’s Medical Center. (May 2025), 143–144.